Canberk Sencan
Dokuz Eylul, 35220, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
First-Line Durvalumab-Tremelimumab in Advanced Hepatocellular Carcinoma: Real-World Data from Turkey.
Journal: Journal of clinical medicine
Published: June 24, 2026
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.
Journal: Journal of clinical medicine
Published: March 01, 2026
Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG).
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: January 06, 2026
Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG).
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: January 06, 2026
Prognostic Impact of Glomerular Filtration Rate Decline on Survival Outcomes in Metastatic Renal Cell Carcinoma Treated with Targeted Therapy.
Journal: Medicina (Kaunas, Lithuania)
Published: August 12, 2025
The association between serum uric acid and survival outcomes in patients with metastatic renal cell carcinoma treated with targeted therapy.
Journal: BMC cancer
Published: June 20, 2025
Total cholesterol/high-density lipoprotein cholesterol ratio is a candidate predictor of survival outcomes in patients with metastatic renal cell carcinoma.
Journal: Scientific reports
Published: February 07, 2025
DPP4 inhibitors as a potential therapeutic option for sarcopenia: A 6-month follow-up study in diabetic older patients.
Journal: Experimental gerontology
Published: January 23, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026